Particularly relevant for basal-like breast cancer (BLBC) and BRCA1-associated breast cancers, studies show that ROS levels correlate with the expression and activity of the transcription factor aryl hydrocarbon receptor (AhR). Here, AHR is linked to breast carcinoma.